I

Immatics NV
D

IMTX

5.55000
USD
-0.14
(-2.46%)
مغلق
حجم التداول
15,535
الربح لكل سهم
0
العائد الربحي
-
P/E
-28
حجم السوق
674,603,438
أصول ذات صلة
AZN
AZN
0.040
(0.06%)
69.630 USD
BNTX
BNTX
0.250
(0.23%)
110.050 USD
GSK
GSK
-0.010
(-0.03%)
38.210 USD
I
INO
-0.07500
(-5.28%)
1.34500 USD
JNJ
JNJ
-0.840
(-0.54%)
155.270 USD
MRNA
MRNA
-0.580
(-1.90%)
29.900 USD
N
NVAX
-0.18000
(-2.65%)
6.61000 USD
PFE
PFE
-0.200
(-0.79%)
25.240 USD
REGN
REGN
-8.77
(-1.60%)
538.11 USD
VRTX
VRTX
0.38
(0.08%)
459.65 USD
المزيد
الأخبار المقالات

العنوان: Immatics NV

القطاع: Healthcare
الصناعة: Biotechnology
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.